Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/20114
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pasiieshvili, Tamara | - |
dc.contributor.author | Zhelezniakova, Natalia | - |
dc.date.accessioned | 2018-06-26T06:19:20Z | - |
dc.date.available | 2018-06-26T06:19:20Z | - |
dc.date.issued | 2018-06-05 | - |
dc.identifier.citation | Pasiieshvili T. M. Аrterial hypertension and diabetes mellitus: the possibility of using dapagliflozin / T. M. Pasiieshvili, N. M Zhelezniakova // Терапевтический вестник. – 2018. – Спец. вып. № 1 (47) : Материалы Х Конгресса Ассоциации кардиологов и V Съезда терапевтов Республики Казахстан, IX Конгресса Ассоциации кардиологов Тюркского мира, посвященные 40-летию Алма-Атинской декларации ВОЗ по ПМСП, Алматы, 5–8 июня 2018 года. – С. 131. | ru_RU |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/20114 | - |
dc.description.abstract | The prevalence of hypertension in patients with type 2 diabetes mellitus is about 80%. This combination of nosological forms at times increases the risk of developing kidney failure, loss of vision, stroke and heart attack. Purpose: to establish the effect of dapagliflozin on the course of arterial hypertension in patients with type 2 diabetes mellitus. | ru_RU |
dc.language.iso | en | ru_RU |
dc.subject | arterial hypertension | ru_RU |
dc.subject | diabetes mellitus | ru_RU |
dc.title | Arterial hypertension and diabetes mellitus: the possibility of using dapagliflozin | ru_RU |
dc.type | Thesis | ru_RU |
Appears in Collections: | Наукові праці. Кафедра загальної практики – сімейної медицини та внутрішніх хвороб |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Казахст.2018ПасиешвилиЛМ.pdf | 526,05 kB | Adobe PDF | View/Open | |
Казахст.2018Титул.pdf | 1,13 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.